January 27, 2015 4:58 AM | 1 min read |
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Novartis AG (NYSE: NVS) reported a drop in its profit for the fourth quarter.Novartis' net profit attributable to shareholders declined to $1.49 billion, compared to $2.03 billion, in the year-ago quarter. The company took $1.1 billion in one-time charge during the quarter. Core net income climbed to $2.91 billion, versus a restated $2.89 billion.EPS dropped 23% to $0.62, while core EPS rose 3% to $1.21.Its sales shrank 2% to $14.63 billion, versus analysts' estimates of $14.68 billion. Excluding currency fluctuations impact, sales gained 4%.Its operating income slipped 49% to $1.2 billion.For this year, the company projects net sales to rise by a mid-single digit percentage versus 2014.Joseph Jimenez, CEO of Novartis, said: “2014 was a transformational year for Novartis. We improved our execution, while taking steps to focus the company on our three leading businesses with global scale. We delivered solid sales growth with margin expansion, strengthened innovation, and advanced our quality and productivity agendas. I'm confident that we are positioned for future success.”Novartis shares fell 0.39% to close at $96.49 yesterday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.